217 related articles for article (PubMed ID: 35481063)
1. A review on α-glucosidase inhibitory activity of first row transition metal complexes: a futuristic strategy for treatment of type 2 diabetes.
Sohrabi M; Binaeizadeh MR; Iraji A; Larijani B; Saeedi M; Mahdavi M
RSC Adv; 2022 Apr; 12(19):12011-12052. PubMed ID: 35481063
[TBL] [Abstract][Full Text] [Related]
2. Heterocyclic Compounds: Effective α-Amylase and α-Glucosidase Inhibitors.
Saeedi M; Hadjiakhondi A; Nabavi SM; Manayi A
Curr Top Med Chem; 2017; 17(4):428-440. PubMed ID: 27558678
[TBL] [Abstract][Full Text] [Related]
3. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
McCue P; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
[TBL] [Abstract][Full Text] [Related]
4. Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes.
Kashtoh H; Baek KH
Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297746
[TBL] [Abstract][Full Text] [Related]
5. Exploring the inhibitory mechanism of piceatannol on α-glucosidase relevant to diabetes mellitus.
Jiang L; Wang Z; Wang X; Wang S; Cao J; Liu Y
RSC Adv; 2020 Jan; 10(8):4529-4537. PubMed ID: 35495253
[TBL] [Abstract][Full Text] [Related]
6. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
7. Probing 2-acetylbenzofuran hydrazones and their metal complexes as α-glucosidase inhibitors.
Khan S; Tariq M; Ashraf M; Abdullah S; Al-Rashida M; Khalid M; Taslimi P; Fatima M; Zafar R; Shafiq Z
Bioorg Chem; 2020 Sep; 102():104082. PubMed ID: 32717690
[TBL] [Abstract][Full Text] [Related]
8. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.
Kurşun-Aktar BS; Adem Ş; Tatar-Yilmaz G; Hameed ZAH; Oruç-Emre EE
J Mol Recognit; 2023 Nov; 36(11):e3061. PubMed ID: 37720970
[TBL] [Abstract][Full Text] [Related]
9. α-glucosidase inhibitors from plants: A natural approach to treat diabetes.
Kumar S; Narwal S; Kumar V; Prakash O
Pharmacogn Rev; 2011 Jan; 5(9):19-29. PubMed ID: 22096315
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel (R)-4-fluorophenyl-1H-1,2,3-triazoles: A new class of α-glucosidase inhibitors.
Avula SK; Khan A; Halim SA; Al-Abri Z; Anwar MU; Al-Rawahi A; Csuk R; Al-Harrasi A
Bioorg Chem; 2019 Oct; 91():103182. PubMed ID: 31404793
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors.
Khan IA; Ahmad M; Ashfaq UA; Sultan S; Zaki MEA
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443347
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
[TBL] [Abstract][Full Text] [Related]
13. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
[TBL] [Abstract][Full Text] [Related]
14. [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors].
Blicklé JF; Andres E; Brogard JM
Rev Med Interne; 1999 Aug; 20 Suppl 3():379s-383s. PubMed ID: 10480189
[TBL] [Abstract][Full Text] [Related]
15. Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation.
Khan SN; Shaheen F; Aleem U; Sheikh S; Tamfu AN; Ashraf S; Ul-Haq Z; Ullah S; Wahab AT; Choudhary MI; Jahan H
Eur J Pharm Sci; 2022 Jan; 168():106045. PubMed ID: 34666184
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of CuSO₄ on α-glucosidase activity in ddY mice.
Yoshikawa Y; Hirata R; Yasui H; Hattori M; Sakurai H
Metallomics; 2010 Jan; 2(1):67-73. PubMed ID: 21072376
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationships of Natural and Synthetic Indole-Derived Scaffolds as α-Glucosidase Inhibitors: A Mini-Review.
Wang J; Lu S; Sheng R; Fan J; Wu W; Guo R
Mini Rev Med Chem; 2020; 20(17):1791-1818. PubMed ID: 32560604
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Fisetin on α-Glucosidase Activity: Kinetic and Molecular Docking Studies.
Shen B; Shangguan X; Yin Z; Wu S; Zhang Q; Peng W; Li J; Zhang L; Chen J
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500738
[TBL] [Abstract][Full Text] [Related]
19. Naringenin inhibits α-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats.
Priscilla DH; Roy D; Suresh A; Kumar V; Thirumurugan K
Chem Biol Interact; 2014 Mar; 210():77-85. PubMed ID: 24412302
[TBL] [Abstract][Full Text] [Related]
20. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.
Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M
Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
